Skip to main content
Fig. 5 | Critical Care

Fig. 5

From: Auxora versus standard of care for the treatment of severe or critical COVID-19 pneumonia: results from a randomized controlled trial

Fig. 5

Eight-point ordinal scale in patients with severe COVID-19 pneumonia with PaO2/FiO2 between 101 and 200. The mean difference was statistically significant from day 7 to day 12 for patients receiving Auxora (n = 6) compared with those receiving standard of care (n = 4; *P < 0.05 versus standard of care). Patients with severe COVID-19 pneumonia were receiving low-flow supplemental oxygen (arm A)

Back to article page
\